Novagenesis Foundation
Records under this name other than the patents Novagenesis Foundation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 10 of 10 · Back to Novagenesis Foundation
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,045,524 | Selective caspase inhibitors and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,453,205 | Methods for Reprogramming Cells and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,528,087 | Methods for Reprogramming Cells and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,017,737 | Methods for reprogramming cells and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,260,046 | Methods for Reprogramming Cells and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,557,123 | Methods for reprogramming cells and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,944,674 | Selective cysteine protease inhibitors and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,795,439 | Methods for reprogramming cells and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,024,722 | Methods for Reprogramming Cells and Uses Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,791,235 | Selective Caspase Inhibitors and Uses Thereof Formerly held Lapsed on the fee record Ended Jul 29, 2026 · High confidence | Lapsed on the fee record | Ended Jul 29, 2026 | High confidence |